Abstract
Successful treatment with low‐dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have